AKCA
Akcea Therapeutics, Inc

872
Loading...
Loading...
Akcea Therapeutics, Inc. is a biopharmaceutical company. It engages in the development and marketing of drugs globally to treat patients with rare and serious diseases using antisense technology. Its primary focus is developing TEGSEDI, a therapy that treats the polyneuropathy caused by hereditary transthyretin-mediated amyloidosis in adults. It also offers a mature pipeline of novel drugs including AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx, and AKCEA-APOCIII-LRx. The company was founded in December 2014 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
294

Frequently Asked Questions

What is Market Cap of Akcea Therapeutics Inc?
What is the 52-week high for Akcea Therapeutics Inc?
What is the 52-week low for Akcea Therapeutics Inc?
What is Akcea Therapeutics Inc stock price today?
What was Akcea Therapeutics Inc stock price yesterday?
What is the PE ratio of Akcea Therapeutics Inc?
What is the Price-to-Book ratio of Akcea Therapeutics Inc?
What is Akcea Therapeutics Inc's EBITDA?
What is the 50-day moving average of Akcea Therapeutics Inc?
How many employess does Akcea Therapeutics Inc has?

Latest AKCA News

View
No AKCA news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.